First‐degree relatives of patients with early‐onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Summary: Background: First‐degree relatives (FDR s) of early‐onset gastric carcinoma (EOGC) patients are at increased risk of cancer development. OLGA/OLGIM (Operative Link on Gastritis/Intestinal Metaplasia Assessment) classifications have been proposed for the identification of individuals at high risk of gastric cancer development. Aim: To estimate the prevalence and severity of premalignant conditions and lesions in FDR s of EOGC patients. Methods: A case–control study was conducted encompassing 103 FDR s of EOGC patients (cases) and 101 age‐ and gender‐matched controls, all submitted to upper GI endoscopy and OLGA and OLGIM used for staging as well as modified versions with exclusion of the biopsies from incisura angularis in the analysis. Results: Helicobacter pylori infection was present in 82% of cases (P = 0.001). Atrophy was present in 70% of cases (OLGA stages I–IV). High‐risk stages (III–IV) were identified only in cases (19%) (P < 0.001). Dysplasia was diagnosed only in cases (n = 7, P = 0.007). The application of OLGIM, modified OLGA and modified OLGIM classifications led to downgrade of stages in comparison with the original OLGA classification (27%, 15% and 30% respectively). In all classification systems, dysplastic lesions clustered (86%) in high‐risk stages. Conclusions: FDR s of EOGC patients have, even at young ages, a high prevalence of H. pylori infection, high‐risk OLGA and OLGIM stages and dysplasia. These patients should undergo accurate endoscopic observation with at least four biopsies in antrum and corpus to allow adequate staging and follow‐up of premalignant conditions and lesions scored in high‐risk stages, in accordance with international guidelines recently proposed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Grading of Gastritis: The Updated Sydney System
Dixon, M. F., Genta, R. M., Yardley, J. H., & Correa, P. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199610000-00001 · Cited by 5,185
Capelle, L. G., de Vries, A. C., Haringsma, J., Ter Borg, F., de Vries, R. A., Bruno, M. J., van Dekken, H., Meijer, J., van Grieken, N. C. T., & Kuipers, E. J. (2010) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2009.12.029 · Cited by 608 · cited 3×
“Another proposed classification system used IM as a phenotypic marker of atrophy (OLGIM – Operative Link on Gastric Intestinal Metaplasia Assessment).(10) Recently, guidelines on follow-up of gastric premalignant lesions and conditions of the stomach recommended four biopsies (two of the antrum and two of the corpus)…”
MethodInfluentialGastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study
RUGGE, M., DE BONI, M., PENNELLI, G., DE BONA, M., GIACOMELLI, L., FASSAN, M., BASSO, D., PLEBANI, M., & GRAHAM, D. Y. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04277.x · Cited by 280
A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia
Dinis-Ribeiro, M., Lopes, C., da Costa-Pereira, A., Guilherme, M., Barbosa, J., Lomba-Viana, H., Silva, R., & Moreira-Dias, L. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.11270 · Cited by 109
Self-citation
Cited by
Pimentel-Nunes, P., Libânio, D., Marcos-Pinto, R., Areia, M., Leja, M., Esposito, G., Garrido, M., Kikuste, I., Megraud, F., Matysiak-Budnik, T., et al. (2019) · Endoscopy · doi:10.1055/a-0859-1883 · Cited by 993
Self-citationGastric cancer: Prevention, screening and early diagnosis
Pasechnikov, V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.13842 · Cited by 436
High prevalence of gastric preneoplastic lesions in east asians and hispanics in the USA
Choi, C. E., Sonnenberg, A., Turner, K., & Genta, R. M. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3591-2 · Cited by 65
Effect of biopsy site on detection of gastric cancer high‐risk groups by OLGA and OLGIM stages
Kim, Y., Kook, M., Cho, S., Lee, J. Y., Kim, C. G., Joo, J., & Choi, I. J. (2017) · Helicobacter · doi:10.1111/hel.12442 · Cited by 26
Metadata
- Authors
- Marcos‐Pinto, R., Carneiro, F., Dinis‐Ribeiro, M., Wen, X., Lopes, C., Figueiredo, C., Machado, J. C., Ferreira, R. M., Reis, C. A., Ferreira, J., Pedroto, I., & Areias, J.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2012-05-02
- Volume
- 35
- Issue
- 12
- Pages
- 1451-1459
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2018098386
- Cited by
- 70
- References
- 4
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: First‐degree relatives of patients with early‐onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. https://app.cochat.ai/papers/10.1111/j.1365-2036.2012.05111.x
- The paper
- Marcos‐Pinto, R., Carneiro, F., Dinis‐Ribeiro, M., Wen, X., Lopes, C., Figueiredo, C., Machado, J. C., Ferreira, R. M., Reis, C. A., Ferreira, J., Pedroto, I., & Areias, J. (2012). First‐degree relatives of patients with early‐onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2012.05111.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.